Quest Diagnostics Completes Acquisition of LifeLabs
Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the completion of its acquisition of LifeLabs from OMERS. The transaction, valued at approximately CAN $1.35 billion (approximately USD $1 billion), including net debt, has received all necessary approvals and is now closed.
“This…
Broken String Biosciences Appoints New Chief Commercial Officer
Broken String Biosciences Appoints New Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Broken String Biosciences (“Broken String”),...
Inocras, Watchmaker Genomics Collaborate on Genomic Innovation
Inocras, Watchmaker Genomics Collaborate on Genomic Innovation
Inocras, a leading innovator in whole genome sequencing and bioinformatics, and Watchmaker Genomics, an expert in genomic tool development for demanding...
Illumina Ventures Adds Two New Experts as Advisors
Illumina Ventures Adds Two New Experts as Advisors
Dr. Timothy Stenzel and Jerry Steiner join as Advisors Illumina Ventures, a leading genomics and precision health venture firm, today...
Texas A&M Health, BurstIQ to Revolutionize Clinical Genomics Research
Texas A&M Health, BurstIQ to Revolutionize Clinical Genomics Research
Texas A&M Health and BurstIQ, a leader in advanced data management, today announced a partnership to leverage LifeGraph®, a graph-powered, end-to-end data...